FindTrial
Sign In

To Study the Efficacy of Priyalbeejadi Lepa in the Management of Darunaka w.s.r Pityriasis Capitis

A Randomized Open Labelled Controlled Clinical Study to evaluate the Efficacy of Priyalbeejadi Lepa in the Management of Darunaka w.s.r Pityriasis Capitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069564
Enrollment
40
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L210- Seborrhea capitis

Interventions

None listed

Sponsors

JAMMU INSTITUTE OF AYURVEDA AND RESEARCH JAMMU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 16-40 years. 2.Patient representing signs and symptoms of Darunaka who will be willing to participate in the study. 3.Subjects willing to participate with written informed consent, which is conveyed in the language which the subject can understand.

Exclusion criteria

Exclusion criteria: 1.Eczema of scalp. 2.Psoriasis of scalp. 3.Immune- compromised conditions. 4.Conditions in which head wash is restricted like Pratishyaya , injuries to scalp etc. 5.Pregnant and lactating women. 6.Subjects with uncontrolled systemic illness including diabetes mellitus, hypertension.

Design outcomes

Primary

MeasureTime frame
Patients of both sexes age group 16 to 40 years of Darunaka will be selected for relieving sign and symptomsTimepoint: Patients of both sexes age group 16 to 40 years of Darunaka will be selected for relieving sign and symptoms—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR POONAM GUPTA

JAMMU INSTITUTE OF AYURVEDA AND RESEARCH JAMMU

drpoonamgupta03@gmail.com9149696904

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026